PapersPMID:41285561
Intermittent hypoxia and caffeine in infants born preterm: the ICAF Randomized Clinical Trial.
What moved
1 findingHow to read these marks →“TNF-α at 38 weeks was 23% lower in the caffeine group compared to placebo, adjusting for baseline and covariates (P < 0.02, Table 3).”
- Study
- RCT
- Dose studied
- caffeine base 5 mg/kg/day once daily, escalating to 5 mg/kg twice daily at 36 weeks PMA, continued through 42 weeks 6 days PMA
- Population
- very preterm infants (<=30 weeks + 6 days gestational age) randomised to extended caffeine therapy through 42 weeks 6 days PMA vs placebo; secondary endpoint
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- preterm infants <30 weeks+6 days gestational age at 16 US hospitals, previously on routine caffeine, randomised after discontinuation to extended caffeine therapy or placebo through 42 weeks+6 days postmenstrual age
- Participants
- 160
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 9
caffeine